Improved renal allograft survival in children treated with FK 506 (tacrolimus) rescue therapy

Howard E. Corey, Vivian Tellis, Richard Schechner, Stuart M. Greenstein

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

FK 506 has been reported to be effective in reversing acute renal allograft rejection that is resistant to steroids and to OKT3. The contribution of FK 506 'rescue' therapy to long-term graft survival has not been determined. We report 23 children transplanted between January 1993 and December 1994, 10 of whom received FK 506 'rescue' therapy. Acute rejection was reversed in 8 of 10, with 7 of the remaining grafts still functioning after a mean follow-up of 10.9 ± 7.8 (SD) months (range 1-26 months). The actuarial 1-year graft survival rate was 86% compared with 66% for historical, controls (P < 0.05). We conclude that FK 506 may provide long-term benefits to children facing allograft loss due to acute rejection.

Original languageEnglish (US)
Pages (from-to)720-722
Number of pages3
JournalPediatric Nephrology
Volume10
Issue number6
DOIs
StatePublished - 1996

Fingerprint

Tacrolimus
Allografts
Kidney
Graft Survival
Muromonab-CD3
Therapeutics
Steroids
Transplants

Keywords

  • Allograft rejection
  • FK 506

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health

Cite this

Improved renal allograft survival in children treated with FK 506 (tacrolimus) rescue therapy. / Corey, Howard E.; Tellis, Vivian; Schechner, Richard; Greenstein, Stuart M.

In: Pediatric Nephrology, Vol. 10, No. 6, 1996, p. 720-722.

Research output: Contribution to journalArticle

Corey, Howard E. ; Tellis, Vivian ; Schechner, Richard ; Greenstein, Stuart M. / Improved renal allograft survival in children treated with FK 506 (tacrolimus) rescue therapy. In: Pediatric Nephrology. 1996 ; Vol. 10, No. 6. pp. 720-722.
@article{dd9307b322ec4236bf740efcd3a71310,
title = "Improved renal allograft survival in children treated with FK 506 (tacrolimus) rescue therapy",
abstract = "FK 506 has been reported to be effective in reversing acute renal allograft rejection that is resistant to steroids and to OKT3. The contribution of FK 506 'rescue' therapy to long-term graft survival has not been determined. We report 23 children transplanted between January 1993 and December 1994, 10 of whom received FK 506 'rescue' therapy. Acute rejection was reversed in 8 of 10, with 7 of the remaining grafts still functioning after a mean follow-up of 10.9 ± 7.8 (SD) months (range 1-26 months). The actuarial 1-year graft survival rate was 86{\%} compared with 66{\%} for historical, controls (P < 0.05). We conclude that FK 506 may provide long-term benefits to children facing allograft loss due to acute rejection.",
keywords = "Allograft rejection, FK 506",
author = "Corey, {Howard E.} and Vivian Tellis and Richard Schechner and Greenstein, {Stuart M.}",
year = "1996",
doi = "10.1007/s004670050198",
language = "English (US)",
volume = "10",
pages = "720--722",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Improved renal allograft survival in children treated with FK 506 (tacrolimus) rescue therapy

AU - Corey, Howard E.

AU - Tellis, Vivian

AU - Schechner, Richard

AU - Greenstein, Stuart M.

PY - 1996

Y1 - 1996

N2 - FK 506 has been reported to be effective in reversing acute renal allograft rejection that is resistant to steroids and to OKT3. The contribution of FK 506 'rescue' therapy to long-term graft survival has not been determined. We report 23 children transplanted between January 1993 and December 1994, 10 of whom received FK 506 'rescue' therapy. Acute rejection was reversed in 8 of 10, with 7 of the remaining grafts still functioning after a mean follow-up of 10.9 ± 7.8 (SD) months (range 1-26 months). The actuarial 1-year graft survival rate was 86% compared with 66% for historical, controls (P < 0.05). We conclude that FK 506 may provide long-term benefits to children facing allograft loss due to acute rejection.

AB - FK 506 has been reported to be effective in reversing acute renal allograft rejection that is resistant to steroids and to OKT3. The contribution of FK 506 'rescue' therapy to long-term graft survival has not been determined. We report 23 children transplanted between January 1993 and December 1994, 10 of whom received FK 506 'rescue' therapy. Acute rejection was reversed in 8 of 10, with 7 of the remaining grafts still functioning after a mean follow-up of 10.9 ± 7.8 (SD) months (range 1-26 months). The actuarial 1-year graft survival rate was 86% compared with 66% for historical, controls (P < 0.05). We conclude that FK 506 may provide long-term benefits to children facing allograft loss due to acute rejection.

KW - Allograft rejection

KW - FK 506

UR - http://www.scopus.com/inward/record.url?scp=0029803129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029803129&partnerID=8YFLogxK

U2 - 10.1007/s004670050198

DO - 10.1007/s004670050198

M3 - Article

C2 - 8971888

AN - SCOPUS:0029803129

VL - 10

SP - 720

EP - 722

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 6

ER -